American Eagle (AEO) Form 144/A Notifies 40,000-Share Sale via Morgan Stanley
Rhea-AI Filing Summary
American Eagle Outfitters (AEO) filed a Form 144/A notifying a proposed sale of 40,000 common shares through Morgan Stanley Smith Barney LLC on 09/08/2025. The filing lists an aggregate market value of $724,856 and reports 173,268,234 shares outstanding. The 40,000 shares were acquired in three open-market purchases paid in cash: 20,000 shares on 06/10/2022, 10,000 on 06/16/2022, and 10,000 on 06/17/2022. The filer reports no securities sold in the past three months and affirms, by signature, that they are not aware of any undisclosed material adverse information about the issuer.
Positive
- None.
Negative
- None.
Insights
TL;DR Routine Rule 144 notice for an insider sale of 40,000 AEO shares; size is small versus outstanding shares.
The filing documents a proposed sale under Rule 144 of 40,000 common shares with an aggregate market value of $724,856, scheduled through Morgan Stanley on 09/08/2025. All 40,000 shares were acquired in open-market purchases in June 2022 and paid in cash. There were no reported sales by the filer in the prior three months. Given the company's 173,268,234 shares outstanding, this sale represents roughly 0.023% of the outstanding shares, indicating limited direct market impact. The disclosure and the seller's attestation to absence of undisclosed material information are standard and consistent with compliance expectations for Rule 144 transactions.
TL;DR Filing appears procedurally complete and includes required attestation; no red flags in the submitted details.
The Form 144/A lists the broker, exact share counts, acquisition dates and payment method, and confirms no sales in the past three months. The signer reiterates the standard representation about lack of material nonpublic information and references intention to follow Rule 10b5-1 provisions if applicable. From a compliance perspective, the record shows clear provenance of the shares and an explicit market sale date, supporting traceability and auditability for regulatory review.